BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22367910)

  • 21. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural products as a robust source of new drugs and drug leads: past successes and present day issues.
    Rishton GM
    Am J Cardiol; 2008 May; 101(10A):43D-49D. PubMed ID: 18474274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
    Genis D; Kirpichenok M; Kombarov R
    Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening strategies for discovery of antibacterial natural products.
    Singh SB; Young K; Miesel L
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomole-scale natural products discovery.
    Molinski TF
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):197-206. PubMed ID: 19333865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guiding principles for natural product drug discovery.
    Camp D; Davis RA; Evans-Illidge EA; Quinn RJ
    Future Med Chem; 2012 Jun; 4(9):1067-84. PubMed ID: 22709251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A natural products approach to drug discovery: probing modes of action of antitumor agents by genome-scale cDNA library screening.
    Luesch H; Abreu P
    Methods Mol Biol; 2009; 572():261-77. PubMed ID: 20694698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of marine natural products.
    Houssen WE; Jaspars M
    Methods Mol Biol; 2012; 864():367-92. PubMed ID: 22367904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural products: an evolving role in future drug discovery.
    Mishra BB; Tiwari VK
    Eur J Med Chem; 2011 Oct; 46(10):4769-807. PubMed ID: 21889825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH; Macarron R
    Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyphenated techniques and their applications in natural products analysis.
    Sarker SD; Nahar L
    Methods Mol Biol; 2012; 864():301-40. PubMed ID: 22367902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
    Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
    Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shaping a screening file for maximal lead discovery efficiency and effectiveness: elimination of molecular redundancy.
    Bakken GA; Bell AS; Boehm M; Everett JR; Gonzales R; Hepworth D; Klug-McLeod JL; Lanfear J; Loesel J; Mathias J; Wood TP
    J Chem Inf Model; 2012 Nov; 52(11):2937-49. PubMed ID: 23062111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematics-guided bioprospecting for bioactive microbial natural products.
    Liu X; Bolla K; Ashforth EJ; Zhuo Y; Gao H; Huang P; Stanley SA; Hung DT; Zhang L
    Antonie Van Leeuwenhoek; 2012 Jan; 101(1):55-66. PubMed ID: 22086462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.